Combined Modalities in the Periorbital Region: Optimal Rejuvenation with Microfocused Ultrasound, Fillers and Neuromodulators

Phase 4

Recruiting

• Conditions: Participants age 30-60 years, have mild to moderate severity of infraorbital hallow and eye ptosis; periorbital, micro-focused ultrasound, hyaluronic acid fillers, botox

• Registration Number: TCTR20220530008
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-30
• Study Completion: 2022-06-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. participants with mild to moderate severity of infraorbital hallow and eye ptosis
2. willing to participate in the study

Exclusion Criteria

1. Pregnant or lactating women
2. Treated with botulinum toxin, filler, micro-focused ultrasound, or laser treatment in the past 12 months
3. Having coagulation disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infraorbital volume improvement Baseline, 2 weeks, 12 weeks, 14 weeks, 16 weeks, 24 weeks Vectra H1

Secondary Outcome Measures

Name	Time	Method
Eyebrow lifting Baseline, 2 weeks, 12 weeks, 14 weeks, 16 weeks, 24 weeks ImageJ,Physician and patient assessment Baseline, 2 weeks, 12 weeks, 14 weeks, 16 weeks, 24 weeks percent improvement,Safety Baseline, 2 weeks, 12 weeks, 14 weeks, 16 weeks Side effects